Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

ABL proto-oncogene 1, non-receptor tyrosine kinase

 H2PU80_PONAB            Unreviewed;       948 AA.
H2PU80;
21-MAR-2012, integrated into UniProtKB/TrEMBL.
21-MAR-2012, sequence version 1.
05-DEC-2018, entry version 49.
SubName: Full=ABL proto-oncogene 1, non-receptor tyrosine kinase {ECO:0000313|Ensembl:ENSPPYP00000022265};
Name=ABL1 {ECO:0000313|Ensembl:ENSPPYP00000022265};
Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Pongo.
NCBI_TaxID=9601 {ECO:0000313|Ensembl:ENSPPYP00000022265, ECO:0000313|Proteomes:UP000001595};
[1] {ECO:0000313|Ensembl:ENSPPYP00000022265, ECO:0000313|Proteomes:UP000001595}
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
Wilson R.K., Mardis E.;
"A 6x draft sequence assembly of the Pongo pygmaeus abelii genome.";
Submitted (FEB-2008) to the EMBL/GenBank/DDBJ databases.
[2] {ECO:0000313|Ensembl:ENSPPYP00000022265}
IDENTIFICATION.
Ensembl;
Submitted (FEB-2012) to UniProtKB.
-!- CATALYTIC ACTIVITY:
Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-
tyrosyl-[protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136,
Rhea:RHEA-COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
ChEBI:CHEBI:46858, ChEBI:CHEBI:82620, ChEBI:CHEBI:456216;
Evidence={ECO:0000256|SAAS:SAAS00897325};
-!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
kinase family. {ECO:0000256|SAAS:SAAS00941529}.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
-----------------------------------------------------------------------
EMBL; ABGA01290839; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; ABGA01290840; -; NOT_ANNOTATED_CDS; Genomic_DNA.
STRING; 9601.ENSPPYP00000022265; -.
Ensembl; ENSPPYT00000023187; ENSPPYP00000022265; ENSPPYG00000019870.
eggNOG; KOG0197; Eukaryota.
eggNOG; COG0515; LUCA.
GeneTree; ENSGT00940000153838; -.
InParanoid; H2PU80; -.
OMA; GAFRESG; -.
OrthoDB; EOG091G0D46; -.
TreeFam; TF105081; -.
Proteomes; UP000001595; Chromosome 9.
GO; GO:0015629; C:actin cytoskeleton; IEA:Ensembl.
GO; GO:0031252; C:cell leading edge; IEA:Ensembl.
GO; GO:0005829; C:cytosol; IEA:Ensembl.
GO; GO:0016604; C:nuclear body; IEA:Ensembl.
GO; GO:0005730; C:nucleolus; IEA:Ensembl.
GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
GO; GO:0032991; C:protein-containing complex; IEA:Ensembl.
GO; GO:0051015; F:actin filament binding; IEA:Ensembl.
GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
GO; GO:0046875; F:ephrin receptor binding; IEA:Ensembl.
GO; GO:0000287; F:magnesium ion binding; IEA:Ensembl.
GO; GO:0030145; F:manganese ion binding; IEA:Ensembl.
GO; GO:0051019; F:mitogen-activated protein kinase binding; IEA:Ensembl.
GO; GO:0038191; F:neuropilin binding; IEA:Ensembl.
GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IEA:Ensembl.
GO; GO:0001784; F:phosphotyrosine residue binding; IEA:Ensembl.
GO; GO:0070064; F:proline-rich region binding; IEA:Ensembl.
GO; GO:0008022; F:protein C-terminus binding; IEA:Ensembl.
GO; GO:0005080; F:protein kinase C binding; IEA:Ensembl.
GO; GO:0042169; F:SH2 domain binding; IEA:Ensembl.
GO; GO:0017124; F:SH3 domain binding; IEA:Ensembl.
GO; GO:0019905; F:syntaxin binding; IEA:Ensembl.
GO; GO:0090135; P:actin filament branching; IEA:Ensembl.
GO; GO:0050798; P:activated T cell proliferation; IEA:Ensembl.
GO; GO:1990051; P:activation of protein kinase C activity; IEA:Ensembl.
GO; GO:0046632; P:alpha-beta T cell differentiation; IEA:Ensembl.
GO; GO:0002322; P:B cell proliferation involved in immune response; IEA:Ensembl.
GO; GO:0050853; P:B cell receptor signaling pathway; IEA:Ensembl.
GO; GO:0001922; P:B-1 B cell homeostasis; IEA:Ensembl.
GO; GO:0060020; P:Bergmann glial cell differentiation; IEA:Ensembl.
GO; GO:0072358; P:cardiovascular system development; IEA:Ensembl.
GO; GO:0070301; P:cellular response to hydrogen peroxide; IEA:Ensembl.
GO; GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl.
GO; GO:0021587; P:cerebellum morphogenesis; IEA:Ensembl.
GO; GO:0048668; P:collateral sprouting; IEA:Ensembl.
GO; GO:0006975; P:DNA damage induced protein phosphorylation; IEA:Ensembl.
GO; GO:0043542; P:endothelial cell migration; IEA:Ensembl.
GO; GO:0007173; P:epidermal growth factor receptor signaling pathway; IEA:Ensembl.
GO; GO:0045184; P:establishment of protein localization; IEA:Ensembl.
GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:Ensembl.
GO; GO:0030035; P:microspike assembly; IEA:Ensembl.
GO; GO:0030514; P:negative regulation of BMP signaling pathway; IEA:Ensembl.
GO; GO:0022408; P:negative regulation of cell-cell adhesion; IEA:Ensembl.
GO; GO:2000773; P:negative regulation of cellular senescence; IEA:Ensembl.
GO; GO:2000352; P:negative regulation of endothelial cell apoptotic process; IEA:Ensembl.
GO; GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IEA:Ensembl.
GO; GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl.
GO; GO:1900272; P:negative regulation of long-term synaptic potentiation; IEA:Ensembl.
GO; GO:0045930; P:negative regulation of mitotic cell cycle; IEA:Ensembl.
GO; GO:1900275; P:negative regulation of phospholipase C activity; IEA:Ensembl.
GO; GO:0071901; P:negative regulation of protein serine/threonine kinase activity; IEA:Ensembl.
GO; GO:0051444; P:negative regulation of ubiquitin-protein transferase activity; IEA:Ensembl.
GO; GO:0001843; P:neural tube closure; IEA:Ensembl.
GO; GO:0060563; P:neuroepithelial cell differentiation; IEA:Ensembl.
GO; GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl.
GO; GO:0038189; P:neuropilin signaling pathway; IEA:Ensembl.
GO; GO:0038083; P:peptidyl-tyrosine autophosphorylation; IEA:Ensembl.
GO; GO:0006909; P:phagocytosis; IEA:Ensembl.
GO; GO:0035791; P:platelet-derived growth factor receptor-beta signaling pathway; IEA:Ensembl.
GO; GO:1905555; P:positive regulation blood vessel branching; IEA:Ensembl.
GO; GO:2000251; P:positive regulation of actin cytoskeleton reorganization; IEA:Ensembl.
GO; GO:1904531; P:positive regulation of actin filament binding; IEA:Ensembl.
GO; GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl.
GO; GO:0090050; P:positive regulation of cell migration involved in sprouting angiogenesis; IEA:Ensembl.
GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IEA:Ensembl.
GO; GO:0051894; P:positive regulation of focal adhesion assembly; IEA:Ensembl.
GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl.
GO; GO:1902715; P:positive regulation of interferon-gamma secretion; IEA:Ensembl.
GO; GO:1900042; P:positive regulation of interleukin-2 secretion; IEA:Ensembl.
GO; GO:1904528; P:positive regulation of microtubule binding; IEA:Ensembl.
GO; GO:0045931; P:positive regulation of mitotic cell cycle; IEA:Ensembl.
GO; GO:1901216; P:positive regulation of neuron death; IEA:Ensembl.
GO; GO:0033690; P:positive regulation of osteoblast proliferation; IEA:Ensembl.
GO; GO:0051353; P:positive regulation of oxidoreductase activity; IEA:Ensembl.
GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl.
GO; GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; IEA:Ensembl.
GO; GO:0051496; P:positive regulation of stress fiber assembly; IEA:Ensembl.
GO; GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; IEA:Ensembl.
GO; GO:2000096; P:positive regulation of Wnt signaling pathway, planar cell polarity pathway; IEA:Ensembl.
GO; GO:0009791; P:post-embryonic development; IEA:Ensembl.
GO; GO:0030516; P:regulation of axon extension; IEA:Ensembl.
GO; GO:0032489; P:regulation of Cdc42 protein signal transduction; IEA:Ensembl.
GO; GO:1903053; P:regulation of extracellular matrix organization; IEA:Ensembl.
GO; GO:0031113; P:regulation of microtubule polymerization; IEA:Ensembl.
GO; GO:1905244; P:regulation of modification of synaptic structure; IEA:Ensembl.
GO; GO:2001020; P:regulation of response to DNA damage stimulus; IEA:Ensembl.
GO; GO:0045580; P:regulation of T cell differentiation; IEA:Ensembl.
GO; GO:0042770; P:signal transduction in response to DNA damage; IEA:Ensembl.
GO; GO:0048536; P:spleen development; IEA:Ensembl.
GO; GO:0034446; P:substrate adhesion-dependent cell spreading; IEA:Ensembl.
GO; GO:0048538; P:thymus development; IEA:Ensembl.
GO; GO:0002333; P:transitional one stage B cell differentiation; IEA:Ensembl.
Gene3D; 3.30.505.10; -; 1.
InterPro; IPR033221; ABL1.
InterPro; IPR015015; F-actin_binding.
InterPro; IPR011009; Kinase-like_dom_sf.
InterPro; IPR000719; Prot_kinase_dom.
InterPro; IPR017441; Protein_kinase_ATP_BS.
InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
InterPro; IPR036860; SH2_dom_sf.
InterPro; IPR008266; Tyr_kinase_AS.
InterPro; IPR020635; Tyr_kinase_cat_dom.
PANTHER; PTHR24418:SF88; PTHR24418:SF88; 1.
Pfam; PF08919; F_actin_bind; 1.
Pfam; PF07714; Pkinase_Tyr; 1.
PRINTS; PR00109; TYRKINASE.
SMART; SM00808; FABD; 1.
SMART; SM00219; TyrKc; 1.
SUPFAM; SSF55550; SSF55550; 1.
SUPFAM; SSF56112; SSF56112; 1.
PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
3: Inferred from homology;
ATP-binding {ECO:0000256|SAAS:SAAS00990534};
Complete proteome {ECO:0000313|Proteomes:UP000001595};
Kinase {ECO:0000256|SAAS:SAAS00897698};
Nucleotide-binding {ECO:0000256|SAAS:SAAS00990534};
Reference proteome {ECO:0000313|Proteomes:UP000001595};
Transferase {ECO:0000256|SAAS:SAAS00897698};
Tyrosine-protein kinase {ECO:0000256|SAAS:SAAS00897698}.
DOMAIN 60 311 Protein kinase.
{ECO:0000259|PROSITE:PS50011}.
SEQUENCE 948 AA; 102857 MW; 0CA269F47DC7BD09 CRC64;
QLYVSSESRF NTLAELVHHH STVADGLITT LHYPAPKRNK PTVYGVSPNY DKWEMERTDI
TMKHKLGGGQ YGEVYEGVWK KYSLTVAVKT LKEDTMEVEE FLKEAAVMKE IKHPNLVQLL
GVCTREPPFY IITEFMTYGN LLDYLRECNR QEVNAVVLLY MATQISSAME YLEKKNFIHR
DLAARNCLVG ENHLVKVADF GLSRLMTGDT YTAHAGAKFP IKWTAPESLA YNKFSIKSDV
WAFGVLLWEI ATYGMSPYPG IDLSQVYELL EKDYRMERPE GCPEKVYELM RACWQWNPSD
RPSFAEIHQA FETMFQESSI SDEVEKELGK QGVRGAVSAL LQAPELPTKT RTSRRAAEHR
DATDVPEMPH SKGQGESDPL DHEPAVSPLL PRKERGPPEG GLNEDERLLP KDKKTNLFSA
LIKKKKKTAP TPPKRSSSFR EMDGQPERRG AGEEEGRDIS NGALAFTPLD TADPAKSPKP
SNGAGVPNGA LRESGGSGFR SPHLWKKSST LTSSRLATGE EEGGGSSSKR FLRSCSASCV
PHGAKDTEWR SVTLPRDLQS TGRQFDSSTF GGHKSEKPAL PRKRAGENRS DQVTRGTVTP
PPRLVKKNEE AADEVFKDIM ESSPGSSPPN LTPKPLRRQV TVASASGLPY KEEAGKGSAL
GTPAAAEPVT PTSKAGSGAP GGTSKGPAEE SRVRRHKHSS ESPGRDKGKL SRLKPAPPPP
PAASAGKAGG KPLQSPSQEV AGEAVLGAKT KASSLVDAVN SDAAKPSQPG ESLKKPVLPA
TPKPQSAKPS GTPISPAPVP STLPSASSAL AGDQPSSTAF IPLISTRVSL RKTRQPPERI
ASGAITKGVV LDSTEALCLA ISRNSEQMAS HSAVLEAGKN LYTFCVSYVD SIQQMRNKFA
FREAINKLEN HLRELQICPA TAGSGPAATQ DFSKLLSSVK EISDIVQR


Related products :

Catalog number Product name Quantity
EIAAB34305 Mouse,Mus musculus,Proto-oncogene c-Ret,Proto-oncogene tyrosine-protein kinase receptor Ret,Ret
EIAAB34304 Cadherin family member 12,CDHF12,Homo sapiens,Human,Proto-oncogene c-Ret,Proto-oncogene tyrosine-protein kinase receptor Ret,RET
E0978h ELISA ERBB2,HER2,Homo sapiens,Human,Metastatic lymph node gene 19 protein,MLN 19,MLN19,NEU,NGL,p185erbB2,Proto-oncogene c-ErbB-2,Proto-oncogene Neu,Receptor tyrosine-protein kinase erbB-2,Tyrosine kin 96T
U0978h CLIA ERBB2,HER2,Homo sapiens,Human,Metastatic lymph node gene 19 protein,MLN 19,MLN19,NEU,NGL,p185erbB2,Proto-oncogene c-ErbB-2,Proto-oncogene Neu,Receptor tyrosine-protein kinase erbB-2,Tyrosine kina 96T
E0978m ELISA Erbb2,Kiaa3023,Mouse,Mus musculus,Neu,p185erbB2,Proto-oncogene c-ErbB-2,Proto-oncogene Neu,Receptor tyrosine-protein kinase erbB-2 96T
E0978m ELISA kit Erbb2,Kiaa3023,Mouse,Mus musculus,Neu,p185erbB2,Proto-oncogene c-ErbB-2,Proto-oncogene Neu,Receptor tyrosine-protein kinase erbB-2 96T
U0978m CLIA Erbb2,Kiaa3023,Mouse,Mus musculus,Neu,p185erbB2,Proto-oncogene c-ErbB-2,Proto-oncogene Neu,Receptor tyrosine-protein kinase erbB-2 96T
EIAAB14724 Feline sarcoma_Fujinami avian sarcoma oncogene homolog,FES,FPS,Homo sapiens,Human,p93c-fes,Proto-oncogene c-Fes,Proto-oncogene c-Fps,Tyrosine-protein kinase Fes_Fps
E0978r ELISA kit Epidermal growth factor receptor-related protein,Erbb2,Neu,p185erbB2,p185neu,Proto-oncogene c-ErbB-2,Proto-oncogene Neu,Rat,Rattus norvegicus,Receptor tyrosine-protein kinase erbB-2 96T
U0978r CLIA Epidermal growth factor receptor-related protein,Erbb2,Neu,p185erbB2,p185neu,Proto-oncogene c-ErbB-2,Proto-oncogene Neu,Rat,Rattus norvegicus,Receptor tyrosine-protein kinase erbB-2 96T
E0978r ELISA Epidermal growth factor receptor-related protein,Erbb2,Neu,p185erbB2,p185neu,Proto-oncogene c-ErbB-2,Proto-oncogene Neu,Rat,Rattus norvegicus,Receptor tyrosine-protein kinase erbB-2 96T
EIAAB39852 Homo sapiens,Human,p60-Src,pp60c-src,Proto-oncogene c-Src,Proto-oncogene tyrosine-protein kinase Src,SRC,SRC1
EIAAB35721 Homo sapiens,Human,Proto-oncogene c-Ros-1,Proto-oncogene tyrosine-protein kinase ROS,ROS1
EIAAB39851 Mouse,Mus musculus,Neuronal proto-oncogene tyrosine-protein kinase Src,p60-Src,pp60c-src,Proto-oncogene c-Src,Src
EIAAB35722 Mouse,Mus musculus,Proto-oncogene c-Ros-1,Proto-oncogene tyrosine-protein kinase ROS,Ros1,Ros-1
EIAAB35719 Proto-oncogene c-Ros-1,Proto-oncogene tyrosine-protein kinase ROS,Rat,Rattus norvegicus,Ros1
EIAAB39850 p60-Src,pp60c-src,Proto-oncogene c-Src,Proto-oncogene tyrosine-protein kinase Src,Rat,Rattus norvegicus,Src
15-288-22631 Receptor tyrosine-protein kinase erbB-2 - EC 2.7.10.1; p185erbB2; C-erbB-2; NEU proto-oncogene; Tyrosine kinase-type cell surface receptor HER2; MLN 19 Polyclonal 0.1 mg
15-288-22631 Receptor tyrosine-protein kinase erbB-2 - EC 2.7.10.1; p185erbB2; C-erbB-2; NEU proto-oncogene; Tyrosine kinase-type cell surface receptor HER2; MLN 19 Polyclonal 0.05 mg
E0978h ELISA kit ERBB2,HER2,Homo sapiens,Human,Metastatic lymph node gene 19 protein,MLN 19,MLN19,NEU,NGL,p185erbB2,Proto-oncogene c-ErbB-2,Proto-oncogene Neu,Receptor tyrosine-protein kinase erbB-2,Tyrosin 96T
18-785-210279 Met (Ab-1234) - EC 2.7.10.1; HGF receptor; Scatter factor receptor; SF receptor; HGF_SF receptor; Met proto-oncogene tyrosine kinase; c-Met Polyclonal 0.05 mg
18-785-210280 Met (Ab-1349) - EC 2.7.10.1; HGF receptor; Scatter factor receptor; SF receptor; HGF_SF receptor; Met proto-oncogene tyrosine kinase; c-Met Polyclonal 0.05 mg
18-785-210280 Met (Ab-1349) - EC 2.7.10.1; HGF receptor; Scatter factor receptor; SF receptor; HGF_SF receptor; Met proto-oncogene tyrosine kinase; c-Met Polyclonal 0.1 mg
10-054-165010 cMet HUMAN - EC 2.7.10.1; HGF receptor; Scatter factor receptor; SF receptor; HGF_SF receptor; Met proto-oncogene tyrosine kinase; c-Met 0.01 mg
18-785-210279 Met (Ab-1234) - EC 2.7.10.1; HGF receptor; Scatter factor receptor; SF receptor; HGF_SF receptor; Met proto-oncogene tyrosine kinase; c-Met Polyclonal 0.1 mg


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur | Gentaur





GENTAUR Ltd.
Unicorn House, Station Cl
Hertfordshire, Potters Bar EN6 1TL
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017
RIB 30004 00187 00010092253 10
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
IBAN FR76 3000 4001 8700 0100 9225 310
france@gentaur.com | Gentaur | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: +49 0241 40 08 90 86, +49 0241 95 78 94 78, +49 0241 40 08 90 86
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur | Gentaur